Lung Cancer Clinical Trials in Minneapolis

Showing 421-440 of 565 trials

Sunitinib Non Small Cell Lung Cancer Patients Over 70

NCT00864721

The purpose of this research study is to find out what effects (good and bad) sunitinib has on patients and their NSCLC.

Non Small Cell Lung Cancer

US Oncology Research63 participantsStarted Feb 2009

Ocala, Florida, United States • Ocoee, Florida, United States • Minneapolis, Minnesota, United States +10 more locations

COMPLETEDPhase 2< 1 mile

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

NCT00527735

The purpose of the study is to determine whether ipilimumab given with paclitaxel/carboplatin has clinical benefit when compared with paclitaxel/carboplatin alone in patients with previously untreated lung cancer.

Lung CancerSmall Cell Lung CancerCarcinoma, Non-Small-Cell Lung

Bristol-Myers Squibb334 participantsStarted Feb 2008

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +69 more locations

Sunitinib Non Small Cell Lung Cancer Patients Over 70

Phase II Study for Previously Untreated Subjects With Non Small Cell Lung Cancer (NSCLC) or Small Cell Lung Cancer (SCLC)

Lung Cancer Trials in Other Cities

Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis

Incidence of SCLN Metastasis in Patients Referred for EBUS-TBNA

Study of Patritumab in Combination With Erlotinib in Subjects With Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC). (HER3-Lung)

Evaluation of a New Anti-cancer Vaccine for Patients With Non-small Cell Lung Cancer, After Tumor Removal by Surgery

The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS)

A Study of CDX-1127 (Varlilumab) in Patients With Select Solid Tumor Types or Hematologic Cancers

A Study of Alectinib (CH5424802/RO5424802) in Participants With Anaplastic Lymphoma Kinase (ALK)-Rearranged Non-Small Cell Lung Cancer (NSCLC)

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Followed by Radiation Therapy and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery

Captopril in Treating Patients With Non-Small Cell Lung Cancer or Limited-Stage Small Cell Lung Cancer That Has Been Previously Treated With Radiation Therapy With or Without Chemotherapy

A Study of Alectinib (RO5424802) in Participants With Non-Small Cell Lung Cancer Who Have Anaplastic Lymphoma Kinase (ALK) Mutation and Failed Crizotinib Treatment

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer

Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer

A Study of Intravenous XMT-1001 in Patients With Advanced Solid Tumors

AZD2014 and Weekly Paclitaxel in Squamous NSCLC

Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients

Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment

Other Conditions in Minneapolis